drugset / Trial / NCT02608320

A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants

NCT02608320

Phase 1 Completed 52 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOther

Summary

The purpose of this study is to evaluate the cumulative adhesion percentage for the test products and the reference products for both small and large patches.

Timeline

Start
2015-11-17
Primary completion
2016-04-13
Completion
2016-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12.5 ug Other
Subject Fentanyl Other / unclassified 100 ug Other

Indications

No indication recorded.